State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Kidney & Renal Pelvis (Late Stage^), 2015-2019

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 4.8 with a 95% confidence interval from 4.8 to 4.9 and 18,746 average annual cases over 2015-2019.
• CI*Rank⋔ : N/A
• Percent of Cases with Late Stage : 28.3

Louisiana³

• Rate : The incidence rate is 6.2 with a 95% confidence interval from 5.9 to 6.5 and 342 average annual cases over 2015-2019.
• CI*Rank⋔ : 1 (1, 6)
• Percent of Cases with Late Stage : 28.1

Iowa³

• Rate : The incidence rate is 6.1 with a 95% confidence interval from 5.8 to 6.5 and 245 average annual cases over 2015-2019.
• CI*Rank⋔ : 2 (1, 9)
• Percent of Cases with Late Stage : 31.9

Kentucky³

• Rate : The incidence rate is 5.9 with a 95% confidence interval from 5.6 to 6.2 and 324 average annual cases over 2015-2019.
• CI*Rank⋔ : 3 (1, 12)
• Percent of Cases with Late Stage : 28.4

West Virginia⁶

• Rate : The incidence rate is 5.8 with a 95% confidence interval from 5.4 to 6.3 and 147 average annual cases over 2015-2019.
• CI*Rank⋔ : 4 (1, 21)
• Percent of Cases with Late Stage : 28.6

Oklahoma⁶

• Rate : The incidence rate is 5.7 with a 95% confidence interval from 5.4 to 6.0 and 267 average annual cases over 2015-2019.
• CI*Rank⋔ : 5 (1, 19)
• Percent of Cases with Late Stage : 28.0

Mississippi⁶

• Rate : The incidence rate is 5.7 with a 95% confidence interval from 5.3 to 6.0 and 203 average annual cases over 2015-2019.
• CI*Rank⋔ : 6 (1, 21)
• Percent of Cases with Late Stage : 25.6

Missouri⁶

• Rate : The incidence rate is 5.5 with a 95% confidence interval from 5.3 to 5.8 and 424 average annual cases over 2015-2019.
• CI*Rank⋔ : 7 (3, 21)
• Percent of Cases with Late Stage : 29.3

Arkansas⁶

• Rate : The incidence rate is 5.5 with a 95% confidence interval from 5.2 to 5.9 and 206 average annual cases over 2015-2019.
• CI*Rank⋔ : 8 (2, 23)
• Percent of Cases with Late Stage : 26.0

Indiana⁶

• Rate : The incidence rate is 5.5 with a 95% confidence interval from 5.3 to 5.8 and 434 average annual cases over 2015-2019.
• CI*Rank⋔ : 9 (3, 21)
• Percent of Cases with Late Stage : 29.2

Wisconsin⁶

• Rate : The incidence rate is 5.5 with a 95% confidence interval from 5.3 to 5.8 and 409 average annual cases over 2015-2019.
• CI*Rank⋔ : 10 (3, 22)
• Percent of Cases with Late Stage : 29.8

Texas³

• Rate : The incidence rate is 5.5 with a 95% confidence interval from 5.4 to 5.6 and 1,581 average annual cases over 2015-2019.
• CI*Rank⋔ : 11 (5, 18)
• Percent of Cases with Late Stage : 27.8

Alaska⁶

• Rate : The incidence rate is 5.4 with a 95% confidence interval from 4.6 to 6.3 and 40 average annual cases over 2015-2019.
• CI*Rank⋔ : 12 (1, 43)
• Percent of Cases with Late Stage : 29.9

Minnesota⁶

• Rate : The incidence rate is 5.4 with a 95% confidence interval from 5.1 to 5.7 and 361 average annual cases over 2015-2019.
• CI*Rank⋔ : 13 (4, 24)
• Percent of Cases with Late Stage : 30.9

Nebraska⁶

• Rate : The incidence rate is 5.4 with a 95% confidence interval from 5.0 to 5.8 and 123 average annual cases over 2015-2019.
• CI*Rank⋔ : 14 (2, 29)
• Percent of Cases with Late Stage : 30.2

New Mexico³

• Rate : The incidence rate is 5.4 with a 95% confidence interval from 5.0 to 5.8 and 139 average annual cases over 2015-2019.
• CI*Rank⋔ : 15 (3, 30)
• Percent of Cases with Late Stage : 34.9

Ohio⁶

• Rate : The incidence rate is 5.3 with a 95% confidence interval from 5.1 to 5.5 and 785 average annual cases over 2015-2019.
• CI*Rank⋔ : 16 (7, 24)
• Percent of Cases with Late Stage : 30.6

Illinois³

• Rate : The incidence rate is 5.3 with a 95% confidence interval from 5.1 to 5.5 and 805 average annual cases over 2015-2019.
• CI*Rank⋔ : 17 (8, 24)
• Percent of Cases with Late Stage : 29.4

Rhode Island⁶

• Rate : The incidence rate is 5.2 with a 95% confidence interval from 4.7 to 5.8 and 70 average annual cases over 2015-2019.
• CI*Rank⋔ : 18 (2, 40)
• Percent of Cases with Late Stage : 31.5

Georgia³

• Rate : The incidence rate is 5.2 with a 95% confidence interval from 5.0 to 5.4 and 599 average annual cases over 2015-2019.
• CI*Rank⋔ : 19 (10, 26)
• Percent of Cases with Late Stage : 29.9

Tennessee⁶

• Rate : The incidence rate is 5.1 with a 95% confidence interval from 4.9 to 5.4 and 425 average annual cases over 2015-2019.
• CI*Rank⋔ : 20 (11, 28)
• Percent of Cases with Late Stage : 26.1

Maine⁶

• Rate : The incidence rate is 5.1 with a 95% confidence interval from 4.6 to 5.6 and 102 average annual cases over 2015-2019.
• CI*Rank⋔ : 21 (4, 40)
• Percent of Cases with Late Stage : 30.7

Kansas⁶

• Rate : The incidence rate is 5.1 with a 95% confidence interval from 4.7 to 5.4 and 176 average annual cases over 2015-2019.
• CI*Rank⋔ : 22 (7, 35)
• Percent of Cases with Late Stage : 26.7

Montana⁶

• Rate : The incidence rate is 5.0 with a 95% confidence interval from 4.4 to 5.6 and 69 average annual cases over 2015-2019.
• CI*Rank⋔ : 23 (4, 44)
• Percent of Cases with Late Stage : 29.6

Wyoming⁶

• Rate : The incidence rate is 4.9 with a 95% confidence interval from 4.2 to 5.7 and 35 average annual cases over 2015-2019.
• CI*Rank⋔ : 24 (2, 49)
• Percent of Cases with Late Stage : 33.3

Idaho³

• Rate : The incidence rate is 4.9 with a 95% confidence interval from 4.4 to 5.3 and 97 average annual cases over 2015-2019.
• CI*Rank⋔ : 25 (8, 44)
• Percent of Cases with Late Stage : 28.1

South Dakota⁶

• Rate : The incidence rate is 4.9 with a 95% confidence interval from 4.3 to 5.5 and 53 average annual cases over 2015-2019.
• CI*Rank⋔ : 26 (5, 48)
• Percent of Cases with Late Stage : 29.9

Vermont⁶

• Rate : The incidence rate is 4.8 with a 95% confidence interval from 4.2 to 5.6 and 42 average annual cases over 2015-2019.
• CI*Rank⋔ : 27 (4, 49)
• Percent of Cases with Late Stage : 31.4

Connecticut³

• Rate : The incidence rate is 4.8 with a 95% confidence interval from 4.5 to 5.1 and 220 average annual cases over 2015-2019.
• CI*Rank⋔ : 28 (18, 41)
• Percent of Cases with Late Stage : 29.7

North Carolina⁶

• Rate : The incidence rate is 4.7 with a 95% confidence interval from 4.5 to 4.9 and 593 average annual cases over 2015-2019.
• CI*Rank⋔ : 29 (22, 40)
• Percent of Cases with Late Stage : 26.8

North Dakota⁶

• Rate : The incidence rate is 4.7 with a 95% confidence interval from 4.1 to 5.4 and 42 average annual cases over 2015-2019.
• CI*Rank⋔ : 30 (5, 49)
• Percent of Cases with Late Stage : 27.2

Pennsylvania⁶

• Rate : The incidence rate is 4.7 with a 95% confidence interval from 4.6 to 4.9 and 797 average annual cases over 2015-2019.
• CI*Rank⋔ : 31 (23, 39)
• Percent of Cases with Late Stage : 27.7

New Jersey³

• Rate : The incidence rate is 4.7 with a 95% confidence interval from 4.5 to 4.9 and 513 average annual cases over 2015-2019.
• CI*Rank⋔ : 32 (22, 41)
• Percent of Cases with Late Stage : 28.2

South Carolina⁶

• Rate : The incidence rate is 4.6 with a 95% confidence interval from 4.4 to 4.9 and 299 average annual cases over 2015-2019.
• CI*Rank⋔ : 33 (22, 43)
• Percent of Cases with Late Stage : 26.4

New York³

• Rate : The incidence rate is 4.6 with a 95% confidence interval from 4.5 to 4.7 and 1,109 average annual cases over 2015-2019.
• CI*Rank⋔ : 34 (25, 40)
• Percent of Cases with Late Stage : 27.2

Washington⁵

• Rate : The incidence rate is 4.6 with a 95% confidence interval from 4.4 to 4.8 and 402 average annual cases over 2015-2019.
• CI*Rank⋔ : 35 (23, 43)
• Percent of Cases with Late Stage : 29.8

New Hampshire⁶

• Rate : The incidence rate is 4.6 with a 95% confidence interval from 4.2 to 5.1 and 85 average annual cases over 2015-2019.
• CI*Rank⋔ : 36 (15, 48)
• Percent of Cases with Late Stage : 28.7

Michigan⁶

• Rate : The incidence rate is 4.6 with a 95% confidence interval from 4.4 to 4.8 and 587 average annual cases over 2015-2019.
• CI*Rank⋔ : 37 (24, 42)
• Percent of Cases with Late Stage : 28.8

Alabama⁶

• Rate : The incidence rate is 4.5 with a 95% confidence interval from 4.3 to 4.8 and 280 average annual cases over 2015-2019.
• CI*Rank⋔ : 38 (24, 45)
• Percent of Cases with Late Stage : 25.0

California³

• Rate : The incidence rate is 4.5 with a 95% confidence interval from 4.4 to 4.6 and 1,958 average annual cases over 2015-2019.
• CI*Rank⋔ : 39 (31, 42)
• Percent of Cases with Late Stage : 29.8

Delaware⁶

• Rate : The incidence rate is 4.4 with a 95% confidence interval from 3.9 to 5.0 and 56 average annual cases over 2015-2019.
• CI*Rank⋔ : 40 (18, 49)
• Percent of Cases with Late Stage : 26.0

Massachusetts³

• Rate : The incidence rate is 4.4 with a 95% confidence interval from 4.2 to 4.6 and 375 average annual cases over 2015-2019.
• CI*Rank⋔ : 41 (28, 46)
• Percent of Cases with Late Stage : 28.5

Arizona⁶

• Rate : The incidence rate is 4.3 with a 95% confidence interval from 4.1 to 4.5 and 372 average annual cases over 2015-2019.
• CI*Rank⋔ : 42 (34, 48)
• Percent of Cases with Late Stage : 27.0

Oregon⁶

• Rate : The incidence rate is 4.3 with a 95% confidence interval from 4.0 to 4.5 and 225 average annual cases over 2015-2019.
• CI*Rank⋔ : 43 (31, 49)
• Percent of Cases with Late Stage : 27.5

Utah³

• Rate : The incidence rate is 4.2 with a 95% confidence interval from 3.9 to 4.6 and 116 average annual cases over 2015-2019.
• CI*Rank⋔ : 44 (28, 49)
• Percent of Cases with Late Stage : 28.3

Florida⁶

• Rate : The incidence rate is 4.2 with a 95% confidence interval from 4.0 to 4.3 and 1,223 average annual cases over 2015-2019.
• CI*Rank⋔ : 45 (40, 48)
• Percent of Cases with Late Stage : 28.2

Hawaii³

• Rate : The incidence rate is 4.1 with a 95% confidence interval from 3.7 to 4.6 and 76 average annual cases over 2015-2019.
• CI*Rank⋔ : 46 (27, 50)
• Percent of Cases with Late Stage : 31.0

Maryland⁶

• Rate : The incidence rate is 4.1 with a 95% confidence interval from 3.9 to 4.3 and 291 average annual cases over 2015-2019.
• CI*Rank⋔ : 47 (40, 49)
• Percent of Cases with Late Stage : 25.5

Virginia⁶

• Rate : The incidence rate is 3.9 with a 95% confidence interval from 3.8 to 4.1 and 395 average annual cases over 2015-2019.
• CI*Rank⋔ : 48 (43, 50)
• Percent of Cases with Late Stage : 25.4

Colorado⁶

• Rate : The incidence rate is 3.9 with a 95% confidence interval from 3.7 to 4.2 and 247 average annual cases over 2015-2019.
• CI*Rank⋔ : 49 (42, 50)
• Percent of Cases with Late Stage : 27.6

District of Columbia⁶

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.5 to 3.7 and 21 average annual cases over 2015-2019.
• CI*Rank⋔ : 50 (47, 50)
• Percent of Cases with Late Stage : 26.9

Puerto Rico⁶

• Rate : The incidence rate is 2.1 with a 95% confidence interval from 1.9 to 2.4 and 87 average annual cases over 2015-2019.
• CI*Rank⋔ : N/A
• Percent of Cases with Late Stage : 23.5

Nevada⁶

• Rate : Data not available for this combination of data selections.
• CI*Rank⋔ : N/A
• Percent of Cases with Late Stage : data not available

Notes:
Created by statecancerprofiles.cancer.gov on 05/29/2023 5:46 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.